Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...

Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Ascentage Pharma is discovering and developing small molecule drugs for the treatment of cancer that block or degrade protein targets implicated in cancer. It has active clinical programs targeting ...

Outsourcing to a contract development and manufacturing organization (CDMO) is a critical step for many biotech companies aiming to advance their programs without building costly internal ...

What are the causes of Parkinson’s disease and current therapeutic approaches? Although the underlying cause of Parkinson’s is unknown, scientists do know that the disease results from a loss of ...